Impact of Rheumatoid Factor Levels on Drug Survival of Certolizumab and Adalimumab in Rheumatoid Arthritis: A Real-World Cohort Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #455; Pres time: Nov 8, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
|